Register for the upcoming 2027 Change Provider Trainings

Join our Provider Relations team members for the virtual provider collaboration session(s). Register Now

Show More

Pharmacy Policies Available Online for Medicaid Expansion and Non-Migrated Members

Blue Cross Blue Shield of North Dakota (BCBSND) continually develops and revises pharmacy policies in response to rapidly changing pharmaceutical requirements. Our commitment is to update the provider community as pharmacy policies are adopted and/or revised.

Medicaid Expansion Updates - Medical Pharmacy

Note: There may be corresponding policies for our Commercial lines of business.

The following Medicaid Expansion medical drug prior authorization policies are new and effective Jan. 1, 2027:

  • Garetosmab-grts (Pasatru)
  • Marnetegragene autotemcel (Kresladi)
  • Pariglasgene brecaparvovec-opnr (Genglycos)
  • Rebisufligene etisparvovec-hopf (Fayuvi)
  • Vusolimogene oderparepvec-wtpg (Tudriqev)

The following Medicaid Expansion prior authorization medical drug policies have coding changes effective Jan. 1, 2027:

  • Immune Globulin Therapy
    • J1459 becomes J1461
    • J1552 becomes J1578
    • J1554 becomes J1579
    • J1556 becomes J1581
    • J1557 becomes J1582
    • J1561 becomes J1583
    • J1566 becomes J1584
    • J1568 becomes J1585
    • J1569 becomes J1586
    • J1572 becomes J1587
    • J1576 becomes J1588
  • Teprotumumab-trbw (Tepezza) and Veligrotug-vvze (Lumvoa)
    • Lumvoa new code J3242
  • Lunsotogene parvec-cwha (Otarmeni)
    • Otarmeni new code J3405
  • Pivekimab Sunirine-pvzy (Decnupaz)
    • Decnupaz new code J9279
  • Trabectedin (Yondelis, Evdi)
    • Evdi new code J9363
  • Bevacizumab (Avastin) and Bevacizumab Biosimilars
    • Avzivi new code Q5174
  • Golimumab (Simponi Aria, Immgolis Intri)
    • Immgolis Intri new code Q5175
  • Intravitreal Injections
    • Ranluspec new code Q5177


Non-Migrated Commercial Updates - Medical Pharmacy

The following Commercial prior authorization medical drug policies are new and effective Jan. 1, 2027, for non-migrated members:

  • Ennumo (pegfilgrastim-pccg)
  • Ranluspec (ranibizumab-hkdz)

Retail Pharmacy

The following retail pharmacy Utilization Management (UM) programs have coding updates effective Jan. 1, 2027:

  • Avzivi (bevacizumab-tnjn)
    • New Code: Q5174
    • Code to be removed: J9999/C9399
  • Immgolis Intri (golimumab-sldi)
    • New Code: Q5175
    • Code to be removed: J3590/C9399
  • Decnupaz (pivekimab sunirine-pvzy)
    • New Code: J9279
    • Code to be removed: J9999/C9313
  • Evdi (trabectedin) [apotex]
    • New Code: J9363
    • Code to be removed: J9999/C9312
  • Lumvoa (veligrotug-vvze)
    • New Code: J3242
    • Code to be removed: J3590/C9399
  • Otarmeni (lunsotogene parvec-cwha)
    • New Code: J3407
    • Code to be removed: J3590/C9399
  • Kresladi (marnetegragene autotemcel)
    • New Code: J3388
    • Code to be removed: J3590/C9399
  • Wainua PFS (eplontersen)
    • New Code: J0226
    • Code to be removed: J3490/C9311